Occupational Exposure To Lead Compounds And Human Cancer
Funder
National Health and Medical Research Council
Funding Amount
$222,887.00
Summary
This study aims to investigate whether there is a link between cancer (in particular cancer of the stomach, lung, kidney and central nervous system) and occupational exposure to lead compounds. There are only a few published cohort studies available on occupational exposures in use and applications of lead compounds, despite the widespread use of these compounds in the past 50 years. Since the late 1980s the use of lead compounds in Australia has decreased, but Australian and world lead producti ....This study aims to investigate whether there is a link between cancer (in particular cancer of the stomach, lung, kidney and central nervous system) and occupational exposure to lead compounds. There are only a few published cohort studies available on occupational exposures in use and applications of lead compounds, despite the widespread use of these compounds in the past 50 years. Since the late 1980s the use of lead compounds in Australia has decreased, but Australian and world lead production has increased. Australia is the world's biggest producer of lead. The precise number of lead workers worldwide is unknown but there are likely to be more than 2 million workers of which many are in developing countries where control of lead exposure is unsatisfactory and occupational exposure limits are considerably higher than in developed countries. Evidence for or against cancer risk with exposure to lead compounds , in particular inorganic lead, will therefore have implications for many Australian and international workers. This is also important for health risk assessment for environmental contamination in the Australian community. In our study we will review the state government archived records of about 8,000 lead workers in New South Wales, Victoria and South Australia, who took part in lead compound exposure surveys and had blood tests in the 1970s, 1980s and 1990s, as part of government lead regulations in force at the time. We will then match the details of these workers against the National Cancer and Death registry data to calculate cancer rates. This should involve a sufficient number of workers to enable us to undertake a comprehensive health evaluation of cancer risk and exposure to lead compounds.Read moreRead less
Integration Of Epidemiological, Biological, And Health Services Data In Cancer Research
Funder
National Health and Medical Research Council
Funding Amount
$290,032.00
Summary
Improved understanding of carcinogenic mechanisms, such as the importance of gene and environment interaction, has placed increased emphasis on the need for studies combining biological and epidemiological data. The proposed research program incorporates a number of cross-disciplinary studies which bridge classical epidemiology and basic science and strive to improve the clinical relevance and translational potential of research outcomes.
Professor Whiteman is a medical epidemiologist with interests in the causes, prevention and treatment of cancer. His fellowship will be directed towards research focussing on methods for controlling cancers of the skin and oesophagus.
A Case Control Study Of Risk Factors For Aggressive Prostate Cancer
Funder
National Health and Medical Research Council
Funding Amount
$1,592,353.00
Summary
Although most prostate cancers are not fatal, some develop into an aggressive form that is likely to progress and kill. How this happens and how to prevent these cancers, is not well understood. The study will examine the lives of men with aggressive prostate cancer, from the time of conception to adulthood, their family history and genetic characteristics to identify the role of life patterns and genes in the development of these cancers, seeking a basis for their prevention .
The Benefits And Harms Associated With Breast Cancer Screening In The Australian Context.
Funder
National Health and Medical Research Council
Funding Amount
$80,222.00
Summary
Australia is caught in a dilemma. Breast screening is well-established however there has been fierce debate about the value of screening programmes. I will determine the frequency of benefit and harm due to breast screening programs in Australia to better understand the true extent of overdiagnosis and overtreatment. Based on this information, I will make recommendations about how breast screening should be provided in Australia in future and clearly communicate this information to the community
Practice- And Policy-relevant Research In Skin Cancer Epidemiology, Prevention And Screening
Funder
National Health and Medical Research Council
Funding Amount
$483,402.00
Summary
This Fellowship will enable me to lead an internationally-competitive program of research in skin cancer epidemiology, prevention & screening that will lead to improved patient and population health through impacts on clinical practice and health policy. My aim is to lead paradigm-shifting contributions in: ? Genetic epidemiology of melanoma, ? Precision skin cancer prevention & screening, and ? Public health genomics for cancer prevention.
Modelling The Possible Effects Of Low-dose Irradiation In Young Australians Exposed To CT Scans
Funder
National Health and Medical Research Council
Funding Amount
$130,877.00
Summary
Radiation from CT (computerised tomographic X-ray) scans of children may cause a later increase in cancer risk. However, any risk for an individual will be small, so we are using de-identified records to study the average risk of cancer in 600,000 young Australians exposed to CT scans between 1985-2005. Our project has the capacity to detect an increase of 10% in the risk of exposed compared with non-exposed. Results will be available by Dec 2012.
Incidence And Prognosis Of Metastatic Breast Cancer: A Population-based Data Linkage Study
Funder
National Health and Medical Research Council
Funding Amount
$97,700.00
Summary
This project will provide the first Australian population-based estimates of metastaticbreast cancer (MBC) incidence and survival in women with an initial diagnosis of early stage cancer that reflect current treatment practices. This evidence will help: women with MBC and their clinicians to make decisions about treatment and plan supportive care; researchers planning trials of MBC therapies, and future planning of cancer services.
Microsimulation Modelling Of Post-Polypectomy Colonoscopy Surveillance Strategies For The Prevention Of Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$101,535.00
Summary
This research will provide a comprehensive evidence-based framework for post-polypectomy endoscopic surveillance in bowel cancer screening. A population-based micro-simulation model of colorectal cancer development will be used to perform epidemiological and health economic evaluations of Australian and international endoscopic surveillance guidelines. These will help inform policy that will potentially lead to improvements in bowel cancer screening and surveillance programs in Australia.